Quinn Opportunity Partners’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-327,551
Closed -$2.53M 409
2025
Q3
$2.53M Hold
327,551
0.18% 119
2025
Q2
$2.85M Hold
327,551
0.24% 104
2025
Q1
$2.61M Buy
327,551
+6,026
+2% +$61K 0.18% 130
2024
Q4
$2.92M Hold
321,525
0.2% 124
2024
Q3
$2.95M Buy
321,525
+5,000
+2% +$41.4K 0.29% 84
2024
Q2
$3.1M Buy
316,525
+80,000
+34% +$976K 0.35% 70
2024
Q1
$3.57M Buy
+236,525
New +$4.29M 0.4% 66

Other funds holding TDOC

Quinn Opportunity Partners's TDOC Position: Q4 2025 in Review

Quinn Opportunity Partners sold out of Teladoc Health (TDOC) in Q4 2025, closing a stake of 327,551 shares — an estimated $2.53M sold.

Quinn Opportunity Partners first reported a position in TDOC in Q1 2024 and held it in 7 quarters. The position peaked at $3.57M in Q1 2024. 344 funds tracked by Wall St. Rank hold TDOC as of Q4 2025.

  • Quinn Opportunity Partners reported no remaining Teladoc Health position as of Q4 2025 after selling out during the quarter.
  • Quinn Opportunity Partners sold 327,551 Teladoc Health shares in Q4 2025, an estimated $2.53M.
  • Quinn Opportunity Partners first reported a position in Teladoc Health in Q1 2024 and held it in 7 quarters.
  • Quinn Opportunity Partners's Teladoc Health position peaked at $3.57M in Q1 2024.
  • 344 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2025.

Based on Quinn Opportunity Partners's 13F filing for Q4 2025, filed 13 Feb 2026.